The Latest Breaking News on Pharma

A week after China eased some of its strictest COVID-19 containment measures, uncertainty remains over the direction of the pandemic

Nick Cannon has revealed the news doctors gave him prior to deciding against his son Zen having chemotherapy last year

The Competition and Markets Authority (CMA) is investigating the price of antibiotics after prices recently are said to have shot up

Pfizer Inc. cemented a deal first announced in March to sell its antiviral medication Paxlovid in China through a state-owned company, adding to supply of COVID treatments in the country that’s now facing a massive infection surge.

Ebola vaccines developed by Johnson Johnson and Merck Co produced virus-fighting antibodies and appear to be safe in children and adults, according to data from two studies published on Wednesday.

It comes as experts urged parents to take up the offer of a flu jab to protect their child from ‘co-infection’.

American health-care giant cites shrinking market share amid stiff competition but will expand other businesses including diagnostics, devices and pharmaceuticals

While the moderate inflation rate for November has boosted investor sentiment and may have paved the way for lower interest rate hikes from this month, Fed’s recent comments suggest that the target interest rate may be a bit further ahead. Hence shares of fundamentally strong businesses with robust demand, such…

The Oireachtas Justice Committee examined the possible legalisation of some drugs

With the Labor Department reporting slower inflation in November and optimism about a reduced magnitude of interest rate hikes, investors are anxiously awaiting a year-end rally. Therefore, fundamentally strong stocks Pfizer (PFE), Murphy USA (MUSA), and Berry Corporation (BRY) could be solid investments now. Keep reading….

Pharmacies have complained they are facing financial ruin amid claims that wholesalers have vastly inflated prices due to demand